Nuveen, LLC Dyne Therapeutics, Inc. Transaction History

Nuveen, LLC

$315 Billion
Q1 2025

A detailed history of Nuveen, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 223,215 shares of DYN stock, worth $2.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

223,215

Holding current value

$2.64 Million

% of portfolio

0.0%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 12, 2025	BUY	$10.46 - $25.46 $2.33 Million - $5.68 Million	223,215 New	223,215 $2.33 Million

Others Institutions Holding DYN

# of Institutions

206

Shares Held

103M

Call Options Held

135K

Put Options Held

435K

Atlas Venture Life Science Advisors, LLC

8.02M
Shares

$94.9 Million
31.16% of portfolio
Vanguard Group Inc Valley Forge, PA

7.41M
Shares

$87.6 Million
0.0% of portfolio
Black Rock Inc. New York, NY

7.39M
Shares

$87.4 Million
0.01% of portfolio
Janus Henderson Group PLC London, X0

7.38M
Shares

$87.3 Million
0.09% of portfolio
Ra Capital Management, L.P. Boston, MA

6.38M
Shares

$75.5 Million
2.43% of portfolio

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $612M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen, LLC with notifications on news.

Account